title: Apneustic respiration normalized by an atypical cholinergic drug action in cats.
abstract: Cats were anesthetized with a mixture of pentobarbital and barbital given intraperitoneally and vagotomized. All animals were pretreated with atropine i.v. which blocked conventional muscarinic receptors and at the same time revealed atropine-insensitive sites whose stimulation by the cholinergic drug, bethanechol, was earlier found to produce respiratory analepsis. Respiration was recorded by pneumotachograph and intrapleural cannula. Apneustic breathing was produced by placing electrolytic lesions in the pneumotaxic area or by injecting a local anesthetic agent into the cerebrospinal fluid. Experiments were performed under isocapnic conditions. Bethanechol, administered intracerebro-ventricularly, restored regular breathing and increased the tidal volume in a dose-related manner within minutes of its injection. In cats with lesions, the expiratory pause generally decreased first and was followed by shortening of the inspiratory plateau. In cats made apneustic by intracerebro-ventricular injection of procaine, bethanechol acted competitively to normalize the distorted waveshape. The central excitant drug pentylenetetrazol was given intravenously for comparison with bethanechol. Apneustic breathing was partially corrected by pentylenetetrazol through a facilitatory influence on the brain stem interpreted to be independent of its convulsant action. These experiments demonstrate correction of pathological breathing by two chemically unrelated agents which share the ability to increase central excitatory state.
mesh_terms: D000818:Animals; D001626:Bethanechol Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D002045:Bupivacaine / Q000009:adverse effects; D002415:Cats; D005260:Female; D008297:Male; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010433:Pentylenetetrazole / Q000008:administration & dosage / Q000627:therapeutic use; D011343:Procaine / Q000009:adverse effects; D012120:Respiration Disorders / Q000628:therapy*; D013238:Stereotaxic Techniques; D014630:Vagus Nerve / Q000502:physiology
chemical_list: D001626:Bethanechol Compounds; D010277:Parasympathomimetics; D011343:Procaine; D010433:Pentylenetetrazole; D002045:Bupivacaine